Application research on the key issues in the diagnosis and treatment of glioma using ultra-high field MRI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031901

Enrollment

Unknown

Registered

2020-04-14

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Age

10 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients initially diagnosed as glioma; 2. Patients who obtained pathological gene test results by operation or biopsy; 3. Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with contraindications of MRI.

Design outcomes

Primary

Measure	Time frame
The size of the tumor;The edge of the tumor;Signal intensity of tumor;	—

Secondary

Measure	Time frame
Extent of edema;	—

Countries

China

Contacts

Public ContactLin Ma

Department of Radiology, Chinese PLA General Hospital

cjr.malin@vip.163.com+86 13801222069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026